Eran Meshorer, PhD

Eran Meshorer, PhD of Hebrew University of Jerusalem, received an ICRF Project Grant for his project entitled, “Histone Turnover in Glioblastoma.” Glioblastoma (GBM) is the most common malignant brain tumor, and it is challenging to treat. A single mutation occurs frequently in a type of GBM that occurs only in pediatric patients. These experiments should identify specific mechanisms by which this mutation may drive malignancy, and potentially identify pathways for therapeutic intervention.

View Grant Recipient profile